HIV-associated tuberculosis in infants, children, and adolescents younger than 15 years: an update on the epidemiology, diagnosis, prevention, and treatment
J Lishman, LJ Frigati, H Rabie - Current Opinion in HIV and AIDS, 2024 - journals.lww.com
Current Opinion in HIV and AIDS Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …
Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study
Background Differentiated service delivery (DSD) for children and adolescents living with
HIV can improve targeted resource use. We derived a mortality prediction score to guide …
HIV can improve targeted resource use. We derived a mortality prediction score to guide …
Treatment of HIV Infection in Children Across the Age Spectrum: Achievements and New Prospects
M Archary, K Mochankana… - Clinics in …, 2024 - perinatology.theclinics.com
Approximately 3.2 million children and adolescents globally living with human
immunodeficiency virus (HIV) require lifelong antiretroviral (ARV) treatment (ART) to prevent …
immunodeficiency virus (HIV) require lifelong antiretroviral (ARV) treatment (ART) to prevent …
Predictors of mortality in Ugandan children with TB, 2016–2021
GL Becker, P Amuge, R Ssebunya… - … of Tuberculosis and …, 2023 - ingentaconnect.com
BACKGROUND: The burden of pediatric TB is high in Uganda. Our objective was to
evaluate predictors of mortality during TB treatment among children at an urban and a rural …
evaluate predictors of mortality during TB treatment among children at an urban and a rural …
[HTML][HTML] Regulatory T Cells Kinetics in Immune Reconstitution Inflammatory Syndrome in HIV-Tuberculosis Co-Infected Individuals
N Barros, CA Sanchez, AC White Jr, A Bauer… - Journal of Molecular …, 2025 - imrpress.com
Background: Combination antiretroviral therapy (cART) can suppress human
immunodeficiency virus (HIV-1) replication, but some patients develop worsening of co …
immunodeficiency virus (HIV-1) replication, but some patients develop worsening of co …